| Name | Title | Contact Details |
|---|
Chambers of Commerce Service Corporation is a Wexford, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Built on the legacy of James Edward Hanger, the first amputee of the American Civil War, Hanger, Inc. (NYSE: HGR) delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger`s Patient Care segment is the largest owner and operator of O&P patient care clinics with in excess of 730 locations nationwide. Through its Products and Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides therapeutic solutions. Steeped in over 150 years of clinical excellence and innovation, Hanger`s vision is to be the partner of choice for products and services that enhance human physical capability. Hanger helps those with limb loss, paralysis, and other physical challenges become productive members of society after injury or illness. Headquartered in Austin, TX and with locations in 45 states, our employees provide personal independence, increased mobility, and restored functionality.
Family Dentistry & Assocs is a Belleville, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1914, Pana Community Hospital has been a place for quality health care. Our employees, medical staff, board of directors and management continue to strengthen and expand our hospital and its’ services. We are committed to your health care future, making our hospital a place you can count on. You can be sure our focus is on today and tomorrow…always striving to bring you quality health care close to home! Our Mission is to be a leading partner in assuring community-based quality Healthcare.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.